RYLPFNYSEX-Ray Apparatus & Tubes & Related Irradiation ApparatusUS GAAP · USD

Koninklijke Philips N.V. NY Registry Shares

Koninklijke Philips N.V. is a Dutch health technology company organized around professional healthcare systems and personal health products. Its business spans diagnostic imaging, ultrasound, image-guided therapy, monitoring, enterprise informatics, and consumer health solutions sold through a global direct and indirect network.

Liiketoiminta

Osuus liikevaihdosta
Diagnostic Imaging30 %

Imaging equipment and related systems used in hospital diagnostics.

Connected Care25 %

Patient monitoring, informatics, and clinical workflow solutions for care settings.

Ultrasound15 %

Ultrasound systems used for diagnostic and procedural imaging.

Image-Guided Therapy15 %

Interventional systems and tools used during minimally invasive procedures.

Personal Health15 %

Consumer health and wellness products for home use.

Asiakkaat

Philips sells primarily to hospitals, health systems, and other healthcare providers that buy capital equipment, software, and service contracts for diagnosis and treatment. It also serves consumers through personal health products used in the home. Buying decisions are driven by clinical performance, installed-base compatibility, workflow integration, and service support.

Hospitals and health systems

Buy imaging, monitoring, and therapy systems for diagnostic and treatment workflows.

Physicians and clinical departments

Use ultrasound, image-guided therapy, and monitoring tools for patient care.

Healthcare IT and operations teams

Buy enterprise informatics and integration tools to manage care data.

Consumers

Buy personal health products for home use and wellness.

Strategia

Philips is focused on combining clinical technologies, software, and service to improve care delivery across the hospital and home. Its strategy centers on innovation in diagnostic imaging, monitoring, and connected care, while using its installed base and global service network to deepen customer relationships.

Clinical innovation in core hospital categoriesKeskipitkä aikaväli

Keeps Philips differentiated in large-ticket medical technology purchases.

Connected care and informaticsKeskipitkä aikaväli

Links devices, data, and workflow across the care continuum.

Service and installed-base monetizationLyhyt aikaväli

Healthcare customers need lifecycle support, upgrades, and integration.

Consumer health portfolioPitkä aikaväli

Provides exposure to home-use health demand beyond hospitals.

Maantiede

Philips operates globally, with sales and services in more than 100 countries and headquarters in the Netherlands. Europe, North America, and Asia are key markets because hospital spending, installed-base service, and consumer health demand are spread across those regions.

Riskit

Philips faces healthcare-equipment cycle risk, because hospital spending and large order timing can move demand between quarters and regions. It is also exposed to regulatory, product quality, reimbursement, and technology-transition risks that are common in medical devices and healthcare IT.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Regulatory and product compliance risk1Large-order timing and capital spending cycles2Technology obsolescence3Supply chain and trade exposure4
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Regulatory and product compliance riskVaikutus: KorkeaTodennäköisyys: Korkea

    Medical devices require approvals, quality control, and post-market monitoring.

    KohdistuuDiagnosticsMonitoringTherapy systems
  2. Large-order timing and capital spending cyclesVaikutus: KeskitasoTodennäköisyys: Korkea

    Imaging and monitoring systems are high-value purchases that can shift between periods.

    Kohdistuu: Hospital equipment demand

  3. Technology obsolescenceVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Clinical platforms must keep pace with imaging, software, and workflow advances.

    Kohdistuu: Installed base and new product launches

  4. Supply chain and trade exposureVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Global manufacturing and cross-border sales create sourcing and tariff risk.

    Kohdistuu: International operations

Kysy Clarifolta: Koninklijke Philips N.V. NY Registry Shares

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Different product, service, and software arrangements may recognize revenue at different times.

Vaikutus: Can shift sales between quarters and affect margin mix

Provisions and estimates

Medical technology firms use judgment for warranties, contingencies, and other obligations.

Vaikutus: Can materially affect operating profit and liabilities

Fair value and hedging

Foreign currency exposure and derivative contracts affect reported results and equity.

Vaikutus: Can create volatility in profit and OCI

Seasonality and order timing

Large healthcare orders can move between periods, especially in regional markets.

Vaikutus: Can distort quarterly comparability

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 28.9.2026